5MinuteHematology

Acalabrutinib + Venetoclax + Obinutuzumab Protocol

Curated Five Minute Hematology reference for Acalabrutinib + Venetoclax + Obinutuzumab. Open the approved protocol in 5MH Tools.

Cll Treatment regimen

Open protocol

Continue to the reviewed 5MH Tools protocol reference for regimen details, schedule, supportive-care context, evidence and source transparency.

Open protocol All 5MH Tools
Protocol reference Acalabrutinib + Venetoclax + Obinutuzumab · Cll · Treatment regimen · v1.0.1
Aliases AVO, AMPLIFY AVO
Medical review Reviewed 2026-10-04 · 14 cycles; obinutuzumab C2-7; venetoclax C3-14
Protocol type Defined multi-drug regimen with a specified treatment schedule.
Source transparency Evidence references are available in the approved 5MH protocol.
For qualified healthcare professionals · Educational and professional reference use only · Verify clinically relevant information against original sources